Dr Eugenia Piliotis

Medicenna Therapeutics Corp, based in Toronto, ON, is a clinical-stage immunotherapy company focused on harnessing directed evolution to create engineered interleukins, referred to as Superkines. These innovative therapies are designed to fine-tune, modulate, or amplify the immune system, aiming to address complex diseases and provide hope for patients with unmet medical needs. The company's pipeline emphasizes the development of interleukin-2, interleukin-4, and interleukin-13 super-agonists and antagonists, enhancing their specificity, functionality, and safety compared to unmodified interleukins. By enabling customizable, multi-functional treatments, Medicenna aims to deliver targeted therapies directly to areas where they are most needed. Generated from the website

FACIT, established by the Ontario Institute for Cancer Research, is dedicated to commercializing world-class cancer innovations and fostering entrepreneurial ventures in Ontario. By leveraging breakthrough innovations and a robust community network, FACIT aims to drive patient impact and economic growth through strategic investments and partnerships in the biotechnology sector. With a focus on bridging the seed funding gap in life sciences, FACIT has successfully attracted private sector investment and facilitated significant clinical trials and job creation. Their initiatives, including the WeSEED program for women-led startups, exemplify their commitment to supporting diverse talent and advancing cancer research commercialization in Ontario. Generated from the website

Photolitec, located in East Amherst, NY, is a company that specializes in a database that is currently blocked, offering solutions for those unsure of what to do in this situation. With their expertise and knowledge, Photolitec provides assistance and guidance to individuals who are experiencing difficulties with their blocked database, ensuring that they find the appropriate resolution.Generated from the website